Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06851936

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
204 (estimated)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Given the challenges to delivering tobacco cessation treatment in oncology care and the unique challenges faced by individuals attempting to quit tobacco after a cancer diagnosis, scalable cessation programs that are tailored to the experiences of cancer survivors that also integrate caregiver/family support are needed. To address this need, this study will use an intervention that consists of two primary strategies: 1) a tailored cessation program for cancer survivors and family members/caregivers who use tobacco and 2) healthcare provider training. Healthcare providers will receive training on the AAC model (Ask patients about tobacco use, Advise patients to quit, Connect patients to cessation resources), including materials focused on tobacco cessation in cancer care from the CDC, as well as a brief evidence-based communication skills training based on the C-LEAR (Counsel, Listen, Empathize, Answer, Recommend) approach.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNicotine cessation programAll participants will complete a nicotine cessation program designed by Area Health Education Center (AHEC). The focus is on known tobacco cessation techniques and motivations to quit with additional focuses on cancer survivors and caregivers. The program consists of 4 sessions (each session is approximately 60 minutes long) that will be delivered by a Tobacco Treatment Specialist by either videoconference or by telephone. Dyad enrollees (i.e., cancer survivors and their caregiver/family member) will complete sessions together. Participants will also be eligible for free nicotine replacement therapy while on study if medically appropriate.

Timeline

Start date
2025-07-11
Primary completion
2026-05-01
Completion
2026-11-01
First posted
2025-02-28
Last updated
2025-07-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06851936. Inclusion in this directory is not an endorsement.